Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 161-180 of 308

Ref Title Date Issued Review
TA89 Cartilage injury - autologous chondrocyte implantation (ACI) (review) (TA89) May 2005 Jan 2012
TA68 Macular degeneration (age-related) - photodynamic therapy (TA68) Sep 2003 Feb 2012
TA171 Multiple myeloma - lenalidomide (TA171) Jun 2009 Feb 2012
TA170 Venous thromboembolism - rivaroxaban (TA170) Apr 2009 Feb 2012
TA129 Multiple myeloma - bortezomib (TA129) Oct 2007 Feb 2012
TA96 Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a (TA96) (partially updated by CG165) Feb 2006 TBC
TA153 Hepatitis B - entecavir (TA153) Aug 2008 Mar 2012
TA154 Hepatitis B - telbivudine (TA154) Aug 2008 Mar 2012
TA173 Hepatitis B - tenofovir disoproxil fumarate (TA173) Jul 2009 Mar 2012
TA248 Diabetes (type 2) - exenatide (prolonged release) (TA248) Feb 2012 May 2012
TA203 Diabetes (type 2) - liraglutide (TA203) Oct 2010 May 2012
TA190 Lung cancer (non-small-cell) - pemetrexed (maintenance) (TA190) Jun 2010 TBC
TA181 Lung cancer (non-small-cell, first line treatment) - pemetrexed (TA181) Sep 2009 TBC
TA192 Lung cancer (non-small-cell, first line) - gefitinib (TA192) Jul 2010 TBC
TA172 Head and neck cancer (squamous cell carcinoma) - cetuximab (TA172) Jun 2009 Jun 2012
TA176 Colorectal cancer (first line) - cetuximab (TA176) Aug 2009 Aug 2012
TA177 Eczema (chronic) - alitretinoin (TA177) Aug 2009 Aug 2012
TA140 Ulcerative colitis (subacute manifestations) - infliximab (TA140) Apr 2008 TBC
TA163 Ulcerative colitis (acute exacerbations) - infliximab (TA163) Dec 2008 TBC
TA183 Cervical cancer (recurrent) - topotecan (TA183) Oct 2009 Sep 2012

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.